In the high-stakes world of psychiatric genetics, the prevailing paradigm has long been a quest for the "genetic signature" of disease. For decades, researchers have painstakingly mapped polygenic risk scores (PRS) to identify the inherited variations that predispose individuals to conditions like bipolar disorder. However, a new study published in Human Genetics and Genomics Advances (HGG Advances) by Dr. Rachel Sharp challenges the adequacy of this narrow focus, arguing that our understanding of mental health is fundamentally incomplete without accounting for the lived realities of patients.
Dr. Sharp’s paper, titled "Considering social risk alongside genetic risk for bipolar disorder in the All of Us Research Program," represents a significant pivot in how geneticists view the intersection of biology and environment. By utilizing the massive, diverse, and environmentally rich dataset of the All of Us Research Program, Sharp demonstrates that social risk factors are not merely "noise" to be filtered out—they are, in fact, co-drivers of disease prevalence that can rival genetic predisposition.
The Genesis of a Holistic Research Agenda
The motivation for Dr. Sharp’s work stems from a career trajectory that began far from the computational suites of a genetics lab. Before her doctoral studies, Sharp worked on an emergency room behavioral assessment team and served as a crisis counselor. These experiences provided her with a visceral understanding of the human condition—an understanding that proved difficult to reconcile with the abstract, de-identified data often used in genomic research.
"It is impossible to separate a person’s psychological symptoms from their daily life," Sharp explains. "Most of the time, these illnesses don’t just appear out of nowhere; their onset and severity are deeply entangled with a person’s environment, financial stability, and support systems."
Observing that current polygenic risk scores often fail to capture the full picture of disease liability, particularly in non-European populations and clinical biobanks, Sharp sought to bridge the gap. Her objective was to transition from a model that treats the genome as the sole arbiter of health to one that treats the individual as a product of both biological inheritance and social experience.
Chronology of a Paradigm Shift
The project’s development followed a rigorous, multidisciplinary path:
- Foundational Observation: Dr. Sharp identified that current psychiatric genetic models often suffer from poor predictive power when applied to real-world cohorts, largely due to a lack of integration of environmental data.
- Cohort Selection: Utilizing the All of Us Research Program—a platform designed specifically to capture social and environmental determinants of health alongside genomic data—allowed for a scale of analysis previously unavailable.
- Methodological Integration: Sharp synthesized techniques from epidemiology, statistics, and social science to quantify "social risk," ensuring that factors such as financial stability and access to healthcare were treated with the same mathematical weight as genetic variants.
- Data Synthesis and Validation: By comparing cohorts with high and low genetic risks against varying levels of social stressors, the team identified a startling convergence: high social risk often acts as a surrogate for genetic vulnerability.
- Dissemination: The findings were peer-reviewed and published in HGG Advances, sparking a conversation about the necessity of incorporating social variables into the standard genetic research toolkit.
Supporting Data: The Convergence of Social and Genetic Risk
The core finding of Dr. Sharp’s research is both intuitive and scientifically disruptive. Her team discovered that individuals who possessed low genetic risk for bipolar disorder but faced a high burden of social risk exhibited rates of the condition comparable to, or even exceeding, those seen in individuals with high genetic risk but low social burden.
This data highlights a critical failure in traditional genetic studies: they often assume that a control group can be standardized. In reality, human lives are inherently messy. When researchers ignore the socioeconomic environment, they fail to see that a diagnostic code—a standard metric in biobank research—may reflect a patient’s inability to access care just as much as it reflects the underlying pathology of the disorder.
"In our cohort, social factors reflect the everyday stressors and healthcare barriers that directly influence both mental health and access to care," says Dr. Sharp. "Even though addressing them is complex, they highlight critical areas where community support, clinical resources, and policy changes can make a difference."
Expert Perspectives and Multidisciplinary Synthesis
The success of this project, according to Dr. Sharp, is rooted in its interdisciplinary design. A singular focus on genetics, she argues, leads to a blinkered view of complex human behaviors. Her research philosophy—that no complex question has a single answer—necessitated a team that could view the data through multiple lenses:
- The Geneticist’s Lens: Focusing on the inheritance of risk alleles.
- The Clinician’s Lens: Evaluating how symptoms manifest in the real world.
- The Epidemiologist’s Lens: Assessing population-level patterns of disease and social exposure.
- The Bioethicist’s Lens: Considering the implications of how we define phenotypes and interpret risk.
By forcing these disciplines into dialogue, Sharp’s work avoids the common pitfall of "genetic determinism." Instead, it treats the patient as a whole person, acknowledging that diagnostic codes are sometimes products of clinician bias or structural inequality, rather than purely biological events.
Implications for the Future of Human Genetics
The broader impact of this research is a call for a more "holistic" approach to the field of human genetics. As Dr. Sharp notes, the "messiness" of human cohorts should not be viewed as a technical barrier to be overcome, but as the essential context in which genetic variation operates.
Rethinking the "Risk" Variant
Dr. Sharp points to recent research involving the Turkana people of Kenya as an example of why this shift is necessary. In that study, a genetic variant associated with cardiometabolic risk was found to be protective for populations living in their ancestral, resource-scarce environment, but detrimental for those living in urban settings. This serves as a potent reminder that genetic variants do not have a fixed "effect." They are essentially "environmental responders."
Policy and Practice
The implications for clinical practice are profound. If social risk factors are as influential as genetic ones, then clinical intervention for bipolar disorder should not stop at the prescription pad. It must extend to the social determinants of health—addressing housing stability, financial security, and access to consistent healthcare.
A New Standard for Research
For the human genetics community, Dr. Sharp’s work establishes a new standard for how data should be interpreted. By demonstrating that social factors act as powerful moderators of genetic risk, she has paved the way for future studies that integrate socioeconomic surveys, environmental exposure data, and clinical history into a single, cohesive framework.
Conclusion: The Human Behind the Data
As a young scientist who recently defended her thesis at the University of North Carolina at Chapel Hill, Dr. Sharp acknowledges the challenges of maintaining a human-centric focus in a field dominated by massive, cold datasets. She admits that moving from patient-facing roles to analyzing thousands of de-identified records requires a deliberate, intentional effort to avoid losing sight of the individuals involved.
"When you spend every day looking at diagnostic billing codes and survey scores on a computer screen, you have to be intentional about centering the human experiences that shaped those records," she reflects. "My multidisciplinary training helps me make connections across fields, question standard methodologies, and keep my research grounded in the communities it’s meant to serve."
Dr. Sharp’s work serves as a necessary wake-up call for the scientific community. By demanding that we consider the "why" and "where" of a patient’s life alongside the "what" of their DNA, she is helping to redefine the future of psychiatric genetics—a future that is as much about the human environment as it is about the human genome.
About the Author
